Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Limited case reports of accidental first-trimester exposure did not report severe adverse outcomes, but extended use carries greater theoretical risk
Ecnoglutide (XW004) is the core of the licensing deal, which is a long half-life oral peptide analog of GLP-1
Rapid weight loss with any peptide tends to cause some muscle loss alongside fat loss
Additionally, insulin, blood glucose level and body mass index (BMI) were measured as secondary outcomes (Figure 5, Figure 6, Figure 7)
Fatima Hussein, MD, serves as Instadrip's Medical Director
Eligibility Not sure where you land
US$ 27.26
US$ 22.71
US$ 26.82
US$ 23.10
US$ 27.53
US$ 28.83
US$ 28.75
US$ 25.52
US$ 26.74
US$ 28.91
US$ 22.14
